Cordis Cites Stent Risk But Still Loses Patent Fight
A Johnson & Johnson Inc. subsidiary's attempt to overturn a patent infringement ruling based on new evidence alleging that its stents caused fatal blood clots has been denied by a Delaware...To view the full article, register now.
Already a subscriber? Click here to view full article